 PARIS CAMBRIDGE, Mass.--BUSINESS WIRE--Regulatory News: NANOBIOTIX Paris:NANO NASDAQ:NBTX Euronext : NANO NASDAQ: NBTX the Company, a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, reported business highlights and financial results for the fiscal year ending December 31, 2020. 2020 was a banner year for Nanobiotix, despite challenges posed by COVID-19. Our company achieved several miles 